Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators. Bhasale A, Mintzes B, Sarpatwari A. BMJ 2020;369:m1107.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhasale A, Mintzes B, Sarpatwari A. Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators. BMJ 2020;369:m1107.
PMID: 32349976